Vascular News and Research

RSS

New ESC Guidelines on diagnosis and treatment of peripheral artery disease

For cardiologists, coronary artery disease is the most important presentation of atherosclerosis. Patients with coronary artery disease may also have symptomatic or asymptomatic atherosclerosis in other vascular areas (peripheral artery disease).

26 Aug 2011

AHA announces new app for cardiologists to access Circulation journal

The American Heart Association (AHA) announced new digital tools that provide members and subscribers advanced access to its Circulation journal through the release of a mobile view website and iPad app.

26 Aug 2011

SuperSonic Imagine introduces UltraFast Doppler technology

SuperSonic Imagine, the ultrasound company that pioneered breakthrough ShearWave Elastography technology, today announced another major breakthrough in ultrasound imaging: UltraFast Doppler.

26 Aug 2011

Covidien pledges $375,000 to SIRF's discovery campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Covidien, a manufacturer of medical devices, pharmaceuticals and medical supplies, based in Mansfield, Mass., has pledged $375,000 and is a "Visionary" level supporter.

26 Aug 2011

Transradial cardiac catheterizations reduce complications, increase patient comfort

Each year, more than one million cardiac catheterizations are performed in the United States, and most of these procedures are performed through the groin to access the arteries that provide blood supply to the heart.

25 Aug 2011

Streamlining esophagectomy reduces hospital stay, cost associated with surgery

Thoracic surgeons at University of Iowa Hospitals and Clinics have found that by altering the pre- and post-surgical care of a patient in need of an esophagectomy they are able to reduce the length of hospital stay by more than two-thirds and have a significant impact on the overall costs.

24 Aug 2011

United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH

United Therapeutics Corporation announced today the completion of its FREEDOM-C(2) Phase 3 trial of treprostinil diethanolamine, an investigational sustained release oral formulation of treprostinil, a stable synthetic form of prostacyclin, in patients with pulmonary arterial hypertension.

24 Aug 2011

Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury

The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Aug 2011

Roche Canada grants Vasculitis and Scleroderma Fellowship

Roche Canada announced today its support of a Vasculitis and Scleroderma Fellowship through the Division of Rheumatology at the University of British Columbia (UBC). Dr. Ada Man, a recent graduate of the UBC rheumatology residency program, is the recipient of the one-year Fellowship.

23 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

itm FlowMedical initiates Rhenium-PTA therapy clinical trial in PAOD

itm FlowMedical GmbH announced the start of OPEN-188 clinical trial. It will compare itm Rhenium-PTA, a therapy for the prevention of restenosis in peripheral vessels, to a regular PTA, the standard therapy for the treatment of PAOD.

23 Aug 2011

KalVista raises £8 million in series A round of funding

KalVista Pharmaceuticals, a new ophthalmology company with a focus on diabetic macular edema (DME), has raised £8 million in a series A round from leading life sciences investors Novo A/S and SV Life Sciences.

23 Aug 2011

Cambridge Memorial Hospital installs Toshiba's CT and ultrasound system

Since quick and accurate diagnosis is critical in an acute setting, Cambridge Memorial Hospital, a critical care hospital in Nebraska operating as part of the integrated Tri Valley Health System, has installed the Aquilion 64 CT system and the Aplio XG ultrasound system from Toshiba America Medical Systems, Inc.

23 Aug 2011

No effective treatment yet for acute lung injury

Patients can essentially drown in their own fluids when trauma and infection prompt blood vessels to leak, flooding millions of air sacs in their lungs.

22 Aug 2011

Research uncovers natural defense mechanism that inactivates C. diff toxins

Groundbreaking research encompassing Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, has uncovered a natural defense mechanism that is capable of inactivating the toxin that spreads Clostridium difficile, or C. diff, an increasingly common bacterial infection in hospitals and long-term care settings.

22 Aug 2011

High levels of calcium in coronary arteries increase risk of stroke, heart attack

The presence of calcium in coronary arteries is a much better predictor of heart attack and stroke than C-reactive protein among people with normal levels of LDL cholesterol, according to a study of more than 2,000 people led by a Johns Hopkins heart specialist.

19 Aug 2011

Conference to discuss latest research on gender disparities in cardiovascular disease

Heart disease has sometimes been considered a men's health issue, but the statistics prove otherwise. In the US alone, more than 42 million women live with the problem. Heart disease is responsible for more than one-third of deaths among American women each year, making it the number one killer of females older than 20.

19 Aug 2011

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.

18 Aug 2011

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.

18 Aug 2011

Abbott initiates ABSORB BVS device clinical trial in coronary artery disease

Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.

18 Aug 2011